Skip to main content
Premium Trial:

Request an Annual Quote

Two Pore Guys Receive $2.8M TB Dx Grant From Bill & Melinda Gates Foundation

NEW YORK (GenomeWeb) – Californian startup Two Pore Guys said today that it has received a $2.8 million grant from the Bill & Melinda Gates Foundation to develop a sensitive, low-cost molecular diagnostic assay for tuberculosis.

As part of the 18-month grant, the firm will use its solid-state nanopore technology to provide a simple, sensitive, and low-cost point-of-care device that it said would be compatible with automated, wireless reporting for resource-poor areas.

Two Pore Guys' devices use silicon nanopore chips to examine a wide range of individual analytes with high sensitivity. In addition, the firm said its workflows support multiplexed multi-modal assays from a single sample source.

"Our point-of-care technology platform offers tremendous value to address medical testing needs in resource-limited areas," Two Pore Guys Cofounder and interim CEO William Dunbar said in a statement. "We hope to make a difference in the lives of millions of people around the world who need better access to affordable TB care."

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.